Ann: Kazia's paxalisib granted Fast Track Designation by FDA, page-62

Seems we are now overdue for some key announcements, and the recent one's were all out of left field but hugely accretive for our company!!

1. St.Jude on DIPG is on the timeline for July/August - overdue
2. Dana-Faber on Brain Mets looks like August/September - any day now
3. Our long, lost friend Cantrixil due Aug/Sept as well - any day now
4. Further update on GBM PII Q4...

Had thought of selling out to try to 'catch the knife', but not a chance with the above potential company making announcements!!! If any of 1, 2 & 4 are positive then our potential market size for paxalisib will multiply the conservative USD1 - 1.5 billion!